Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aveanna Healthcare Holdings (AVAH) Current Assets (2021 - 2026)

Aveanna Healthcare Holdings (AVAH) has disclosed Current Assets for 5 consecutive years, with $502.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets rose 31.79% year-over-year to $502.6 million, compared with a TTM value of $502.6 million through Sep 2025, up 31.79%, and an annual FY2024 reading of $392.7 million, up 24.7% over the prior year.
  • Current Assets was $502.6 million for Q3 2025 at Aveanna Healthcare Holdings, up from $449.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $502.6 million in Q3 2025 and bottomed at $269.8 million in Q4 2022.
  • Average Current Assets over 5 years is $342.1 million, with a median of $318.2 million recorded in 2023.
  • The sharpest move saw Current Assets decreased 15.29% in 2022, then soared 31.79% in 2025.
  • Year by year, Current Assets stood at $342.7 million in 2021, then fell by 21.29% to $269.8 million in 2022, then rose by 16.73% to $314.9 million in 2023, then rose by 24.7% to $392.7 million in 2024, then increased by 28.0% to $502.6 million in 2025.
  • Business Quant data shows Current Assets for AVAH at $502.6 million in Q3 2025, $449.9 million in Q2 2025, and $407.6 million in Q1 2025.